Metoclopramide CAS 364-62-5: Your Solution for Effective Anti-Emetic Treatment
An advanced pharmaceutical ingredient for treating nausea and vomiting, backed by quality assurance.
Get a Quote & SampleProduct Core Value
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
This pharmaceutical-grade compound, identified by CAS 364-62-5, is a highly effective anti-emetic agent. Its efficacy stems from its ability to inhibit dopamine receptors in the chemoreceptor trigger zone of the medulla, providing relief from vomiting associated with specific causes.
- Discover the mechanism of action for this anti-emetic drug, crucial for understanding its therapeutic benefits.
- Explore options for online purchase of Metoclopramide CAS 364-62-5, ensuring access to this vital sickness medicine.
- Learn about the high quality standard, with a minimum assay of 99.0%, making it a reliable pharmaceutical ingredient.
- Investigate the specific applications for drug induced vomiting treatment, a key benefit of this chemical.
Advantages You Can Rely On
Superior Efficacy
Experience potent central anti-emetic effects, surpassing many other compounds, ensuring effective relief from nausea and vomiting.
Targeted Application
This sickness medicine is specifically beneficial for vomiting caused by drugs, uremia, and radiotherapy, offering precise therapeutic intervention.
Assured Quality
With a minimum assay of 99.0% and SGS certification, you can trust the high quality standard of this pharmaceutical-grade chemical.
Key Applications
Pharmaceutical Formulation
As a key active pharmaceutical ingredient, it's integral to formulations designed for sickness medicine and the treatment of nausea.
Chemotherapy Support
Provides critical support in managing vomiting induced by chemotherapy, improving patient comfort and treatment compliance.
Post-Treatment Recovery
Aids in recovery from conditions like uremia by mitigating associated emetic symptoms, contributing to better patient outcomes.
Radiotherapy Side-Effect Management
Effectively combats vomiting as a side effect of radiotherapy, enhancing the patient's quality of life during treatment.